🟢 Senti Biosciences is trading 5.74% up in pre-market as Nasdaq Composite gains 0.84%

Senti Biosciences is trading 5.74% up at $0.40 in pre-market after no clear company-specific catalyst was identified for August 25, 2026.

• The move follows a stronger pre-market backdrop, with the Nasdaq Composite up 0.84% and broader U.S. futures higher.
• Recent company disclosures include $4.0 million of senior secured convertible notes issued to Celadon on August 14; that financing is not a new catalyst.